한국어
English
日本語
中文(简体)
Giselleca Tablet 200 mg (Filgotinib Maleate)
254.48mg
Tablet · Prescription medication
Eisai Korea Co., Ltd.
Filgotinib maleate is an immunosuppressive ingredient that regulates inflammation and immune responses in autoimmune diseases.
MFDS ingredient code M282443
Filgotinib maleate belongs to the Janus kinase (JAK) inhibitor class of drugs. It is mainly used for the treatment of autoimmune diseases such as rheumatoid arthritis, and is used to manage excessive immune responses.
Filgotinib maleate selectively inhibits the JAK enzymes responsible for intracellular signaling in immune cells. This blockage prevents cytokine signals that trigger inflammation, leading to reduced inflammation and immune responses.
Approved uses differ by product. Check each product's information for its actual use.
Filgotinib maleate is characterized by its high selectivity compared to other JAK inhibitors, as it inhibits only specific JAK enzymes, thereby reducing the risk of side effects. Additionally, the convenience of oral administration is a distinguishing advantage.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
